Analyst Reco. Definitive Healthcare Corp.

Equities

DH

US24477E1038

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
5.17 ^USD	-3.36%		-26.04%	-47.99%

May. 09	Barclays Adjusts Price Target on Definitive Healthcare to $7 From $11, Maintains Equal-Weight Rating	MT
May. 09	Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Adjusts Price Target on Definitive Healthcare to $7 From $11, Maintains Equal-Weight Rating	May. 09	MT
Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating	May. 09	MT
Stifel Adjusts Price Target on Definitive Healthcare to $9.50 From $11, Maintains Buy Rating	May. 08	MT
Morgan Stanley Downgrades Definitive Healthcare to Equalweight From Overweight, Cuts Price Target to $9 From $11.50	May. 08	MT
Deutsche Bank Adjusts Definitive Healthcare Price Target to $10 From $9, Maintains Hold Rating	Mar. 01	MT
Barclays Adjusts Price Target on Definitive Healthcare to $11 From $10, Maintains Equalweight Rating	Mar. 01	MT
Stifel Adjusts Definitive Healthcare's Price Target to $11 From $12, Keeps Buy Rating	Jan. 17	MT
Needham Downgrades Definitive Healthcare to Hold From Buy	Jan. 17	MT
Canaccord Genuity Downgrades Definitive Healthcare to Hold From Buy, Price Target is $10	Jan. 05	MT
Barclays Raises Definitive Healthcare Price Target to $10 From $7, Maintains Equal Weight Rating	Dec. 27	MT
Deutsche Bank Cuts Definitive Healthcare Price Target to $9 From $14, Maintains Hold rating	Nov. 06	MT
Morgan Stanley Lowers Price Target on Definitive Healthcare to $9.50 From $15.50, Maintains Overweight Rating	Nov. 03	MT
Goldman Sachs Adjusts Price Target on Definitive Healthcare to $10.50 From $17, Keeps Neutral Rating	23-08-15	MT
Credit Suisse Adjusts Price Target on Definitive Healthcare to $11 From $12, Keeps Neutral Rating	23-08-15	MT
Canaccord Genuity Adjusts Price Target on Definitive Healthcare to $12 From $13, Maintains Buy Rating	23-08-15	MT
Morgan Stanley Adjusts Price Target on Definitive Healthcare to $15.50 From $17, Maintains Overweight Rating	23-08-15	MT
BofA Adjusts Price Target on Definitive Healthcare to $10.50 From $12, Keeps Neutral Rating	23-08-15	MT
Baird Downgrades Definitive Healthcare to Neutral From Outperform, Price Target is $13	23-07-24	MT
Barclays Adjusts Price Target on Definitive Healthcare to $10 From $11, Maintains Equalweight Rating	23-05-08	MT
Credit Suisse Lowers Definitive Healthcare's Price Target to $12 From $15, Keeps Neutral Rating	23-05-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Definitive Healthcare Corp.

Equities

DH

US24477E1038

Analyst Reco.

Filters